Oncology > Nova Content
Studies conducted at Thomas Jefferson University’s Kimmel Cancer Center have revealed that removing a lipoprotein receptor known as SR-BI may help protect... Read More »
Researchers of North Shore-LIJ Health System and the Feinstein Institute for Medical Research discovered that microRNA, a genetic marker embedded in DNA, indicates if ... Read More »
Those who take aspirin daily in order to lower the risk of heart attack and stroke may also be preventing cancer. Who knew that such an accessible and cheap drug... Read More »
Comments
Angela HernandezYes, factors like the environment and the foods we eat could contribute to cancer, and as with any cancer treatment or drug currently recommended, there is no guarantee that they would be successful. However, this new NOSH-aspirin has shown its potency and effectiveness on human cancer cells and colon cancer tumors. Based on this new drug’s results, I believe that aspirin does merit further investigation for cancer prevention and treatment.
Apr 5, 2012
Homa YahyaviAspirin does not help. I do not have scientific back up for it. But I have seen in the people who have been using aspirin for many years for the same reason stated in article and being healthy diagnosed with deadly cancer!! It is the environment we live in which is toxic. People's body are different and react differently to different things.
Apr 5, 2012
A new microfluidics-based microarray developed by a team at McGill University could potentially change how and when cancer is diagnosed. The group measured the... Read More »
Northwestern University scientists have developed a specialized nanoparticle, called nanostars, that can deliver a drug directly to a cancer cell’s nucleus. The ... Read More »
Researchers of North Shore-LIJ Health System and the Feinstein Institute for Medical Research discovered that microRNA, a genetic marker embedded in DNA, indicates if ... Read More »
Ninety percent of head and neck cancer cases are due to squamous cell carcinoma -- a cancer of the epithelial cells. Oral squamous cell carcinoma (OSCC) affects ... Read More »
Targeted therapeutic nanoparticles that accumulate in tumors while bypassing healthy cells have shown promising results in an ongoing clinical trial, according to a... Read More »
An international team of scientists mapped the genomes of 100 triple negative breast cancer tumors, the deadliest form of the disease, and discovered that no two... Read More »
A long-term follow-up of a clinical trial has shown promising results for patients with non-small cell lung cancer (NSCLC). The findings, presented at the American... Read More »
Researchers have developed a new cell and animal model of inflammatory breast cancer (IBC), a very aggressive form of the disease that is diagnosed more frequently in ... Read More »
Researchers have discovered how arsenic exposure can turn normal stem cells into cancer stem cells and spur tumor growth. Michael Waalkes and his team at the National ... Read More »
A harmless virus may be able to boost the effects of two standard chemotherapy drugs. RT3D, trade name Reolysin, is a new drug developed by Oncolytics Biotech. It is... Read More »
Rapamycin is a widely used drug for cancer and transplant patients, and there are hints that it might even help us put off old age and live longer. But, it also comes ... Read More »
A new drug developed by Northwestern Medicine scientists prevented human prostate cancer cells from spreading to other tissues without any toxic effects to normal... Read More »
New Harvard School of Public Health research suggests that routine mammograms may in fact lead to a significant amount of overdiagnosis of disease that would... Read More »
Robotic-assisted surgical removal of cancerous bladders is a new approach to the traditional ‘open’ -- or more invasive -- operation called a radical... Read More »
A new study has linked the long-term use of both estrogen plus progesterone and estrogen-only hormone therapy (HT) with a higher risk for developing breast cancer... Read More »
Scientists at the University of California, Los Angeles have discovered that a second mutation found in the tumors of patients with BRAF-mutated metastatic melanoma... Read More »
The results of a new study on patients with breast cancer show that the HER2-based peptide vaccine AE37 had immunologic responses compared with a control substance... Read More »